Search For "randeep guleria"
COVAXIN trial results on children likely by September: AIIMS chief
Updated : 13 hours, 11 min ago IST
New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences (AIIMS) director Randeep Guleria informed.
Read More
May need COVID-19 vaccine booster shots for emerging variants: AII
Updated : 1 day, 8 hours ago IST
New Delhi [India], July 23 (ANI): With various mutations of the SARS-CoV-2 emerging in the near future, there might be a need for the country to adopt a booster dose with second-generation COVID-19 vaccines, said All India Institute of Medical Sciences (AIIMS) chief Dr Randeep Guleria. Read More
The virus will not mutate "dramatically" in the forthcoming months
Updated : 1 day, 8 hours ago IST
New Delhi [India], July 23 (ANI): Director of All India Institute of Medical Sciences in Delhi, Dr Randeep Guleria said that the virus will not mutate "dramatically" in the forthcoming months.
Read More
Graded reopening of schools is advisable: AIIMS Director Dr Guleri
Updated : 1 day, 9 hours ago IST
New Delhi [India], July 23 (ANI): All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria on Friday said the schools in the areas where the Covid positivity rate is low can be reopened.
Read More
Third-wave may not come if COVID norms are followed, vaccination d
Updated : 3 weeks, 2 days ago IST
New Delhi [India], July 1 (ANI): If people are careful and India is able to vaccinate a large number of population, then the third wave of COVID-19 pandemic may not even come, said All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria on Thursday.
Read More
Not much data on Delta plus variant to suggest it's more infectiou
Updated : 3 weeks, 2 days ago IST
New Delhi [India], July 1 (ANI): The Director of All India Institute of Medical Sciences (AIIMS), Delhi, Dr Randeep Guleria on Thursday said that there is not much data available on the Delta plus variant to suggest that it is more infective or has a higher rate of mortality.
Read More
National Doctor's Day: Here's why doctors are more than just heroe
Updated : 3 weeks, 2 days ago IST
New Delhi [India], July 1 (ANI/Mediawire): Being a doctor in today's day and age is an act of unabated selflessness. The Hippocratic oath has become a charter of destiny and a beckoning like no other: Doctors today are required to risk their very lives to save lives each day.
Read More
Need to look ahead, strengthen public health system, says AIIMS di
Updated : 3 weeks, 5 days ago IST
New Delhi [India], June 28 (ANI): As India prepares for the possibility of a third wave of Covid-19 infections and deals with the new variants of Coronavirus like Delta Plus, there is a need to strengthen the public health care system of the country, said Dr Randeep Guleria, All India Ins
Read More
Oxygen committee report is interim report and not final one, says
Updated : 4 weeks ago IST
New Delhi [India], June 27 (ANI): All Indian Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria on Saturday said that the oxygen committee report is an interim report and not the final one and the matter is subjudice.
Read More
We should work on strategies for physical classes in schools, says
Updated : 1 month ago IST
New Delhi [India], June 23 (ANI): Noting that physical schools are useful because they help individuals to grow, AIIMS Delhi Director Dr Randeep Guleria on Wednesday suggested "aggressively working" for the opening of schools and said that online education due to the situation created by COV
Read More
Vaccination, surveillance, appropriate behaviour vital to avoid th
Updated : 1 month ago IST
New Delhi [India], June 23 (ANI): AIIMS Delhi Director Dr Randeep Guleria has said that appropriate behaviour, good surveillance and vaccination are important to avoid the third wave of COVID-19 and noted that mutation of the virus is a matter of concern.
Read More
India likely to have COVID vaccine for children above 2 years by S
Updated : 1 month ago IST
New Delhi [India], June 23 (ANI): Noting that children usually have a mild disease but there is a need to develop COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has said Bharat Biotech and other companies are doing trials at a very fast pace and hoped that data will l
Read More